Form 4: Kura Oncology Executive Sells Shares
Insider Transaction (Form 4)
Mollie Leoni, Chief Medical Officer of Kura Oncology, Inc., sold 41,250 shares of common stock on September 28, 2026.
Summary
- Open-market sale: disposed of 12,448 Common Stock at $10.50 ($130,670) on September 28, 2026; holds 169,897 after (Direct).
- Open-market sale: disposed of 28,802 Common Stock at $10.75 ($309,567) on September 29, 2026; holds 141,095 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $440,237 of stock on the open market.
Insider Transactions
Mollie Leoni — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-28 | Open-market sale | Common Stock | 12,448 | $10 | $130.7K | 169,897 |
| 2026-09-29 | Open-market sale | Common Stock | 28,802 | $11 | $309.6K | 141,095 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-28 | Open-market sale (12,448 shares) |
| 2026-09-29 | Open-market sale (28,802 shares) |
Keywords
insider transaction, Form 4, KURA, Kura Oncology, Inc., bearish, Mollie Leoni
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.